Post by IQVIA

The FDA recently highlighted an IQVIA and Roche Diagnostics collaboration as an example of a regulatory decision supported by real-world evidence—enabling a diagnostic labeling expansion using data from on-the-ground public health. This work reflects how fit-for-purpose RWE can address specific evidence gaps and directly support regulatory action that impacts patient care. Read the study: https://bit.ly/44wMJWc